Ansari R - Search Results

1

Phase III trial of cyclophosphamide versus cyclophosphamide, doxorubicin, and methotrexate in hormone-refractory prostatic cancer. A Hoosier Oncology Group study.

Saxman S, Ansari R, Drasga R, Miller M, Wheeler B, McClean J, Einhorn L. Saxman S, et al. Among authors: ansari r. Cancer. 1992 Nov 15;70(10):2488-92. doi: 10.1002/1097-0142(19921115)70:10<2488::aid-cncr2820701016>3.0.co;2-9. Cancer. 1992. PMID: 1423178 Clinical Trial.

2

Etoposide, ifosfamide, and cisplatin in extensive small cell lung cancer.

Loehrer PJ Sr, Rynard S, Ansari R, Songer J, Pennington K, Einhorn L. Loehrer PJ Sr, et al. Among authors: ansari r. Cancer. 1992 Feb 1;69(3):669-73. doi: 10.1002/1097-0142(19920201)69:3<669::aid-cncr2820690312>3.0.co;2-v. Cancer. 1992. PMID: 1309677 Clinical Trial.

3

Phase II trial of high-dose cisplatin plus etoposide plus vinblastine in non-small-cell lung cancer. A Hoosier Oncology Group study.

Eklund E, Miller ME, Ansari R, Fisher WB, Einhorn LH. Eklund E, et al. Among authors: ansari r. Am J Clin Oncol. 1991 Oct;14(5):412-5. doi: 10.1097/00000421-199110000-00010. Am J Clin Oncol. 1991. PMID: 1659175 Clinical Trial.

4

Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier Oncology Group study.

Loehrer PJ Sr, Ansari R, Gonin R, Monaco F, Fisher W, Sandler A, Einhorn LH. Loehrer PJ Sr, et al. Among authors: ansari r. J Clin Oncol. 1995 Oct;13(10):2594-9. doi: 10.1200/JCO.1995.13.10.2594. J Clin Oncol. 1995. PMID: 7595712 Clinical Trial.

5

Carboplatin (CBDCA) plus alpha interferon in metastatic non-small cell lung cancer. A Hoosier Oncology Group phase II trial.

Mandanas R, Einhorn LH, Wheeler B, Ansari R, Lutz T, Miller ME. Mandanas R, et al. Among authors: ansari r. Am J Clin Oncol. 1993 Dec;16(6):519-21. doi: 10.1097/00000421-199312000-00012. Am J Clin Oncol. 1993. PMID: 8256769 Clinical Trial.

6

Phase II trial of daily oral etoposide in patients with advanced non-small cell lung cancer.

Saxman S, Loehrer PJ Sr, Logie K, Stephens D, Workman F, Scullin D, Einhorn LH, Ansari R. Saxman S, et al. Among authors: ansari r. Invest New Drugs. 1991 Aug;9(3):253-6. doi: 10.1007/BF00176978. Invest New Drugs. 1991. PMID: 1664423 Clinical Trial.

7

Methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic breast cancer. A phase II trial of the Hoosier Oncology Group.

Roth BJ, Sledge GW Jr, Williams SD, Meyer SC, Ansari R, Fisher WB. Roth BJ, et al. Among authors: ansari r. Cancer. 1991 Jul 15;68(2):248-52. doi: 10.1002/1097-0142(19910715)68:2<248::aid-cncr2820680205>3.0.co;2-4. Cancer. 1991. PMID: 2070321 Clinical Trial.

8

Etoposide and split-dose cisplatin in bronchogenic carcinoma.

Lauer RC, Fisher WB, Pennington K, Ansari R, Einhorn LH, Loehrer PJ. Lauer RC, et al. Among authors: ansari r. Am J Clin Oncol. 1988 Dec;11(6):634-5. doi: 10.1097/00000421-198812000-00008. Am J Clin Oncol. 1988. PMID: 3189229

9

Phase II trial of vinblastine, ifosfamide, and gallium combination chemotherapy in metastatic urothelial carcinoma.

Einhorn LH, Roth BJ, Ansari R, Dreicer R, Gonin R, Loehrer PJ. Einhorn LH, et al. Among authors: ansari r. J Clin Oncol. 1994 Nov;12(11):2271-6. doi: 10.1200/JCO.1994.12.11.2271. J Clin Oncol. 1994. PMID: 7525884 Clinical Trial.

10

Phase II study of daily oral etoposide plus ifosfamide plus cisplatin for previously treated recurrent small-cell lung cancer: a Hoosier Oncology Group Trial.

Faylona EA, Loehrer PJ, Ansari R, Sandler AB, Gonin R, Einhorn LH. Faylona EA, et al. Among authors: ansari r. J Clin Oncol. 1995 May;13(5):1209-14. doi: 10.1200/JCO.1995.13.5.1209. J Clin Oncol. 1995. PMID: 7738623 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

443 results

Search Page